NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- RFA-CA-27-007
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.399 Cancer Control
- 93.395 Cancer Treatment Research
- 93.393 Cancer Cause and Prevention Research
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- County Governments
- Tribal Organizations (Not Federally Recognized)
- 501(c)(3) Nonprofits
- State Governments
- Other
- Special District Governments
- Higher Education Inst. (Private)
- Tribal Governments (Federally Recognized)
- For Profit Organizations
- Small Businesses
- City/Township Governments
- Higher Education Inst. (Public)
- Non-501(c)(3) Nonprofits
- Independent School Districts
- Public or Indian Housing Auth.
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Cancer Institute seeks applicants to establish NCORP Community Sites—consortia of community hospitals and oncology practices conducting cancer control, prevention, treatment, and care delivery research in community settings—with applications due September 18, 2026. This is a cooperative agreement (UG1) that explicitly prohibits clinical trials as primary activities; applicants must affiliate with NCORP Research Bases to support trial participation and provide community input on protocol development. The NCI intends to commit $73 million across up to 50 awards for both Community and Academic Community Sites combined, with individual award budgets determined by anticipated annual patient accruals and infrastructure costs and a required 6-year project period beginning September 18, 2027.
Eligible applicants include higher education institutions (public and private), nonprofits (501(c)(3) and non-501(c)(3)), for-profit organizations, government entities (county, state, city, tribal, special district), and other organizational types, but exclude NCI-Designated Cancer Centers, academic medical centers, Department of Veterans Affairs hospitals, military treatment facilities, and foreign organizations or components. No cost-share requirement is specified in the source material.
Community Sites must accrue annually at least 70 new unique adult patient participants (50 for pediatric sites) evenly distributed between cancer control/prevention/screening trials and treatment/imaging trials, with optional participation in cancer care delivery studies requiring a minimum of three active protocols per year. The evaluation emphasizes the applicant's ability to contribute to NCORP goals, engage representative patient populations in a defined catchment area, and demonstrate significant prior accrual history. Applications must include organizational charts, accrual history tables, operational procedures, data management plans, recruitment strategies, and institutional commitment letters from all participating affiliates.
This opportunity is assigned to CFDA 93.395 (Cancer Treatment Research), 93.393 (Cancer Cause and Prevention Research), and 93.399 (Cancer Control). All PD/PIs must register with eRA Commons and ORCID; applicants must complete SAM registration, obtain Unique Entity Identifiers, and register with Grants.gov prior to submission.
Synopsis
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN)NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:NCORP Research Bases (UG1 Clinical Trials Required);NCORP Community Sites (UG1 Clinical Trials Not Allowed)(covered by this NOFO); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed).The NCORP Community Sites is a healthcare system, a consortium of healthcare systems, or a consortia of community hospitals and/or oncology practices, public hospitals, and/or health care centers that can enhance the representativeness of participants accrued to cancer control, prevention, treatment and care delivery clinical trials and other human subjects research conducted through NCORP and NCTN.
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Files
| File | Type | Posted |
|---|---|---|
| PKG00292877.pdf | ||
| RFA-CA-27-007-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity